Rosuvastatin.com is for Sale!
I used to respond to asking price requests with the subject title, “How much are you offering?”
These days, if you don’t mention a number over $xxx,xxx, I probably won’t respond to your inquiry. To be clear, I understand the value of Rosuvastatin.com to the right buyer. To sell this keyword dot-Com domain name, I’ll have to receive a substantial and competitive offer.
If you’re not offering over $xxx,xxx I’m not interested.
Understand, I’ve done my research into the size and future outlook for the Rosuvastatin market through 2030.
According to Fierce Pharma, the Rosuvastatin market generates revenues of at least $5 Billion annually over the last 10 years. Rosuvastatin has stood at the top of the cardiovascular drugs heap for a generation and this trend will continue.
Rosuvastatin is used along with a proper diet to help lower “bad” cholesterol and fats (such as LDL, triglycerides) and raise “good” cholesterol (HDL) in the blood. It belongs to a group of drugs known as “statins.” It works by reducing the amount of cholesterol made by the liver. Lowering “bad” cholesterol and triglycerides and raising “good” cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking.
According to Big Pharma Wall Street analysts, Rosuvastatin has been growing rapidly in the commercial space for the past two decades. In 2018, in the U.S., incidences of cardiovascular treatments rose up a significant percentage on average. Therefore, statins accounted for a significant share in the treatment of cardiovascular conditions.
The outlook for the Rosuvastatin market over the next 10 years is exceedingly positive.
“Sales Value of $6.2 billion in 2018!”
” After Rosuvastatin was launched, its sales value grew sharply. Rosuvastatin has become a key product of statins. In 2012, Rosuvastatin became the number one lipid-lowering drug in the world with a sales value of USD 6.2 billion. “
~ Yahoo Finance (2018)
“Rosuvastatin market will rise at a considerable rate!”
“The global Rosuvastatin Calcium market growth is anticipated to rise at a considerable rate during the forecast period, between 2021 and 2026. In 2021, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.”
~ Market Watch (March 2021)